Millipore Forms Collaboration with Agilent Technologies to Expand Capabilities in Epigenetics Research Market
Millipore Corporation and Agilent Technologies Inc. announced they have formed a collaboration to develop ChIP (chromatin immunoprecipitation) kits for the fast-growing epigenetics research market. The kits will be designed to improve protein researchers’ productivity and simplify the way they study genetic information. ChIP is a technique that helps researchers understand the relationship between DNA and the proteins that impact gene regulation.
“This collaboration brings together two industry leaders to improve scientific workflows for epigenetic researchers,” said Geoffrey Crouse, Vice President of Millipore’s Life Science Strategic Business Unit. “Our long history of leadership in the ChIP market coupled with Agilent’s leadership in DNA microarrays will enable us to help scientists push the frontiers of epigenetic research. We expect to help epigenetics researchers minimize the barriers of entry into chromatin state mapping, readily obtain reproducible genomic profiling data, and overcome the traditional challenges of ChIP assays.”
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
New DNA-method tracks fish and whales in seawater
Listen to the toilet — it could detect disease - Microphone sensor and machine learning can classify excretion events, identify cholera or other bowel diseases, all without identifiable information
WALDNER Laboreinrichtungen GmbH & Co. KG: Changes in the Management
Science on the back burner: European laboratories struggle with massive restrictions - Great sustainability ambitions and willingness to innovate despite the need to save money
QIAGEN acquires additional PCR licenses from Roche and Idaho Technology
BIOTECON Diagnostics signs license agreement with Applera Corporation
The first spectroscopic measurement of an anti-atom - Berkeley Lab scientists helped build and operate the ALPHA antimatter trap at CERN, which has now probed the internal structure of the antihydrogen atom for the first time